ETR:HNL Dr. Hönle (HNL) Stock Price, News & Analysis → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free HNL Stock Alerts €20.20 +0.20 (+1.00%) (As of 04/23/2024 ET) Add Compare Share Share Today's Range€20.20▼€20.3050-Day Range€15.35▼€20.2052-Week Range€15.00▼€24.50Volume118 shsAverage VolumeN/AMarket Capitalization$122.41 millionP/E RatioN/ADividend Yield0.99%Price TargetN/A Stock AnalysisStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Get Dr. Hönle alerts: Email Address Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now About Dr. Hönle Stock (ETR:HNL)Dr. Hönle AG engages in the supply of industrial UV technologies and systems in Germany and internationally. The company operates through three segments: Adhesives, Equipment & Systems, and Glass & Lamps. The Adhesives segment provides industrial adhesives for applications, such as consumer electronics, automotive, optics and opto-electronics, medical technology, and glass processing. The Equipment & Systems segment engages in the provision of solutions used for drying inks and coatings, curing adhesives and plastics, disinfecting surfaces, and solar simulation. The Glass & Lamps segment offers quartz glass tubing and rods for the lamp, automotive, semiconductor, and fibre cable industries, as well as lamps for water disinfection, and the drying of coatings and adhesives. The company was founded in 1976 and is headquartered in Munich, Germany.Read More HNL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HNL Stock News HeadlinesApril 23, 2024 | americanbankingnews.comDr. Hönle (ETR:HNL) Trading Up 1.3%April 22, 2024 | finance.yahoo.comShareholders in Dr. Hönle (ETR:HNL) are in the red if they invested five years agoApril 23, 2024 | TradeSmith (Ad)The A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...April 18, 2024 | finanznachrichten.dePTA-AFR: Dr. Hönle AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114-117 WpHGMarch 25, 2024 | finance.yahoo.comDr. Hönle AG's (ETR:HNL) top owners are retail investors with 54% stake, while 25% is held by private companiesFebruary 27, 2024 | finance.yahoo.comDr. Hönle First Quarter 2024 Earnings: €0.15 loss per share (vs €0.26 profit in 1Q 2023)February 15, 2024 | health.usnews.comDr. Susan N. MizunoFebruary 6, 2024 | travel.usnews.comFree Things To Do in Honolulu - OahuApril 23, 2024 | Wall Street Star (Ad)This Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.February 4, 2024 | finance.yahoo.comDr Hoenle AG (HNL.HM)February 4, 2024 | finance.yahoo.comThe Returns On Capital At Dr. Hönle (ETR:HNL) Don't Inspire ConfidenceFebruary 3, 2024 | morningstar.comDr Hoenle AG HNLDecember 20, 2023 | au.finance.yahoo.comDr. Hönle AG (HNL.F)December 2, 2023 | travel.usnews.comGetting Around Honolulu - OahuNovember 15, 2023 | finance.yahoo.comShould You Investigate Dr. Hönle AG (ETR:HNL) At €18.25?October 24, 2023 | msn.comThis Hawaii dermatologist didn’t realize it then, but his call helped his patient beat cancerOctober 24, 2023 | finance.yahoo.comCalculating The Intrinsic Value Of Dr. Hönle AG (ETR:HNL)October 5, 2023 | finance.yahoo.comFurther weakness as Dr. Hönle (ETR:HNL) drops 10% this week, taking five-year losses to 75%September 21, 2023 | health.usnews.comDr. Lyle T. TenjomaSeptember 1, 2023 | finance.yahoo.comDr. Hönle AG's (ETR:HNL) top owners are individual investors with 60% stake, while 20% is held by institutionsAugust 17, 2023 | health.usnews.comDr. Andrew InabaAugust 12, 2023 | health.usnews.comDr. Weilin BonoAugust 2, 2023 | health.usnews.comDr. John HaJuly 29, 2023 | health.usnews.comDr. James S. TamaiJuly 29, 2023 | health.usnews.comDr. Peter KyriakakisJuly 22, 2023 | health.usnews.comDr. Michael R. UmakiJuly 22, 2023 | health.usnews.comDr. Samuel M. IshimuraSee More Headlines Receive HNL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Dr. Hönle and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeETR SectorIndustrials Industry Electrical Equipment & Parts Sub-IndustryN/A Current SymbolETR:HNL CUSIPN/A CIKN/A Webwww.hoenle.de Phone49 89 85608 0FaxN/AEmployees581Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)(€2.34) Trailing P/E RatioN/A Forward P/E Ratio14.13 P/E Growth-0.39Net Income$-13,830,000.00 Net Margins-13.48% Pretax MarginN/A Return on Equity-13.56% Return on Assets1.09% Debt Debt-to-Equity Ratio58.79 Current Ratio2.19 Quick Ratio0.85 Sales & Book Value Annual Sales$102.56 million Price / Sales1.19 Cash Flow€1.03 per share Price / Cash Flow19.54 Book Value€15.38 per share Price / Book1.31Miscellaneous Outstanding Shares6,060,000Free FloatN/AMarket Cap$122.41 million OptionableNot Optionable Beta1.48 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesDr. Franz Richter (Age 69)Chairman of the Management Board, MD & CEO Comp: $374.4kPeter WeinertHead of Investor RelationsKey CompetitorsVartaETR:VAR1BAUER AktiengesellschaftETR:B5AKoenig & BauerETR:SKBAumannETR:AAGHeidelberger Druckmaschinen AktiengesellschaftETR:HDDView All Competitors HNL Stock Analysis - Frequently Asked Questions How have HNL shares performed in 2024? Dr. Hönle's stock was trading at €17.50 at the beginning of the year. Since then, HNL shares have increased by 15.4% and is now trading at €20.20. View the best growth stocks for 2024 here. Is Dr. Hönle a good dividend stock? Dr. Hönle (ETR:HNL) pays an annual dividend of €0.20 per share and currently has a dividend yield of 1.09%. This page (ETR:HNL) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeHow to camouflage a factory of 53,000 workersStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Hönle AG Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
